Transitioning to Buprenorphine for Pain
Refractory pain not responsive traditional opioids and pain management strategies can be difficult to manage. Escalating doses or a transition to subcutaneous or intravenous route of administration can result in variable responses and may require changes in routine or even patient care setting, adding burden to the patient and considerable additional therapy cost to care. The burgeoning awareness of the pain-relieving benefits of buprenorphine resulting from the 2022 updated CDC Clinical Practice Guideline for Prescribing Opioids for Pain have led some clinicians to consider the drug in the hospice setting for patients experiencing uncontrolled pain....Read More
